Nobivac LoVo L4

Authorised

This medicine is authorised for use in the European Union

leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, inactivated / leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, inactivated / leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, inactivated / leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, inactivated

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.

Product details

• Name of medicine:
  Nobivac LoVo L4
• Active substance:
  Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated,Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated,Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated,Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated,
• International non-proprietary name (INN) or common name:
  leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, inactivated / leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, inactivated / leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, inactivated / leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, inactivated

Authorisation details

• EMA product number:
  EMEA/V/C/005628

Assessment history

Initial marketing authorisation documents

CVMP summary of positiv eopinion for Nobivac LoVo L4

Reference Number: EMA/CVMP/424834/2023